180 Life Sciences Corp. (NASDAQ: ATNF) is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world’s biggest drivers of disease – inflammation. The Company is driving groundbreaking studies into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The Company’s primary platform is a novel program to treat fibrosis using anti-TNF (tumor necrosis factor).
| Website | https://www.180lifesciences.com/ |
| Employees | 2 (1 on RocketReach) |
| Founded | 2013 |
| Phone | +1 727-547-4700 |
| Technologies |
JavaScript
,
HTML
,
PHP
+20 more
(view full list)
|
| Industry | Biotechnology Research, Drug Discovery |
| Keywords | Biotechnology, Drug Development, Pharmaceutical Research, Life Sciences, Clinical Stage, Novel Therapies, Biopharma, Inflammatory Diseases, Pain Management, Therapeutics, Clinical Trials, Fibrosis Treatment, Unmet Medical Needs, Nasdaq, Medicine, Research, Development, Science, Health, Healthcare |
Looking for a particular 180 Life Sciences employee's phone or email?
180 Life Sciences Questions
Jonathan Rothbard is the Founder and Chief Scientific Officer of 180 Life Sciences.
1 people are employed at 180 Life Sciences.
Top 180 Life Sciences Employees
-
Jonathan Rothbard
Founder and Chief Scientific Officer at 180 Life Sciences
Menlo Park, CA, US35+
Related Companies
